LIQUID FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS

摘要

The present invention is directed to liquid formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA2, compositions containing the same and processes for manufacture thereof.